Centre Hospitalier Du Pays D Aix Centre Hospitalier Intercommunal Aix-Pertuis — Clinical Trial Site

38 Registered trials

20 Currently recruiting

Organisation

Centre Hospitalier Du Pays D Aix Centre Hospitalier Intercommunal Aix-Pertuis

Location

Aix En Provence, France

Identifier

ORG-100046299

Address

Avenue Des Tamaris, 13100, France

Departments

1816 :Rhumatologie
1816: Rheumatology
anesthésie-réanimation
Cardiology/EP
Gastroenterology
Hematology
hematology and oncology
Hematology Department
Maladies respiratoires
Médecine interne - Rhumatologie
medecine neonatale
Médecine physique et réadaptation
Neurology
ONCO HEMATOLOGIE MEDECINE INTERNE
Onco-hematology
Oncologie
Oncology
Pneumology
Pneumology Oncology
Réanimation polyvalente
Respiratory disease
Respiratory disease department
Respiratory Diseases
Respiratory Diseases Service
Respiratory medicine
Rhumatology
Service de Neurologie
Service de Pneumologie
Service de Pneumologie et d'Allergologie
Service des maladies respiratoires

Clinical trials at this site (38)

Search interface

PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended

2023-505972-32-00 locally advanced anal squamous cell carcinoma 5 2024-02-26
Durvalumab (immunotherapy) maintenance after thoracic chemoradiotherapy (CRT) in frail small cell lung cancer patients whose disease is limi… Ended

2024-512224-11-00 Histologically confirmed frail Limited Disease Small Ce 4 2023-03-24
Reduction of hormone therapy duration in women with hormonesensitive breast cancer at very low risk of metastatic recurrence Ended

2024-514480-26-00 Post-menopausal women with localized luminal A breast c 4 2022-10-12
Phase III randomized trial of atezolizumab in elderly patients with advanced Non-Small-Cell Lung Cancer and receiving monthly carboplatin wi… Ended

2024-515946-17-00 Non Small Cell Lung Cancer 5 2019-07-22
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neck Ended

2024-513206-65-00 resected squamous cell carcinoma of head and neck 5 2018-08-10
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson’s Disease (BeyoND) Ended

2024-513548-27-00 Parkinson's disease 4 2016-10-05
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
TOXSIALO-TRIAL : Evaluation of the long-term efficacy of the injection of botulinum toxin A into the salivary glands versus scopolamine patc… Ended

2024-512160-58-00 Cerebral palsy with pathological drooling 6 2025-02-12
A randomized, open-label, controlled phase III trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab … Ended

2024-513697-22-00 non-small-cell lung cancer 5 2024-11-07
"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations (MIRANDA)" Ended

2023-505543-39-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-02-12
A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab a… Ended

2022-501895-25-00 Polymyalgia Rheumatica 5 2023-09-13
SHORT RUN AF "Rivaroxaban versus standard of care for patients with excessive atrial ectopy or short atrial runs and high embolism risk" Ended

2024-516374-29-00 Patients with excessive supraventricular ectopies or sh 11 2023-04-18
Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease… Ended

2024-514347-28-00 Men and women over 18 years of age with renal failure r 5 2022-06-02
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02